Drug Profile
FOL 00Y
Alternative Names: FOL-00YLatest Information Update: 14 Sep 2022
Price :
$50
*
At a glance
- Originator Follicum AB
- Developer Coegin Pharma
- Class Peptides
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Unspecified